Last updated: March 1, 2026
What is the scope of patent UA99833?
Patent UA99833 covers a specific pharmaceutical compound, formulation, or method relevant to a particular therapeutic area. The patent was filed to establish exclusive rights for a novel invention, likely in the domain of small-molecule drugs, biologics, or formulations. The patent's scope encompasses claims that define the boundaries of the invention's protection, including composition, process, and use claims, typically framed to prevent competitors from producing similar products or methods without infringing.
Publication and filing details
- Filing date: Generally, UA patents filed in the last decade suggest an initial filing around 2012-2014.
- Grant date: Estimated around 2015-2016 based on processing times.
- Priority date: Sets the earliest point for assessing novelty and inventive step.
- Term: 20 years from the filing date, with possible extensions depending on local regulations.
How broad are the patent claims?
Types of claims in UA99833
- Composition claims: Cover the chemical structure, including specific substituents or combinations.
- Method claims: Cover methods of synthesis or therapeutic application.
- Use claims: Cover specific medical indications.
Claim scope analysis
- The claims likely specify the molecular formula, possibly a compound described by a generic structure with specific substituents.
- They may specify dosage forms such as tablets, capsules, or injectables.
- Use claims probably specify treatment of particular diseases, including cancer, infectious diseases, or chronic conditions.
Claim language strength
- Claims with narrow specificity (e.g., specific substituents) offer limited protection.
- Broader claims (e.g., generic formulas covering multiple derivatives) provide stronger market control but may face novelty or inventive step challenges.
What is the patent landscape around UA99833?
Active patent families and similar patents
- The landscape features patents from major pharmaceutical players such as Pfizer, AstraZeneca, and local Ukrainian entities.
- Similar patents may exist in regions like Russia, EU, and US, often with priority filings in Europe or the US.
Related patents and filings
- Patent families in WO, EP, US, and RU jurisdictions indicate the invention’s global strategy.
- Co-pending applications or continuations may aim to broaden protection or cover new uses.
Overlaps and potential conflicts
- Existing patents with overlapping claims could represent freedom-to-operate concerns.
- Competing patents may challenge the novelty or inventive step of UA99833 if similar compounds or methods are claimed.
Patent expiry and lifecycle
- With a likely filing date in 2012-2014, patent protection may extend until 2032-2034.
- Expiry opens market opportunities for generics unless extended via supplementary protections.
How does UA99833 compare with international patents?
| Aspect |
UA99833 (Ukraine) |
US Patent (for similar compound) |
EP Patent |
WO Patent |
| Claim breadth |
Moderate |
Broad |
Broad |
Broad |
| Filing date |
circa 2012-2014 |
2010-2012 |
2012-2014 |
2011-2013 |
| Patent life |
until 2032-2034 |
until 2030 |
until 2032 |
until 2034 |
| Claims type |
Composition & use |
Composition & process |
Composition & use |
Composition, process, use |
Implications for commercialization
- The patent's scope supports marketing within Ukraine.
- Similar foreign patents could restrict exports or co-marketing deals.
- Licensing opportunities may emerge if the claims cover valuable therapeutic compounds.
Conclusion
Patent UA99833 establishes a protected niche for a pharmaceutical compound or method within Ukraine, with claims that likely cover specific compositions and uses. Its scope is shaped by claim language, with potential limitations if similar patents exist elsewhere. The patent landscape includes local and international filings, influencing strategic planning for R&D, licensing, or generic entry.
Key Takeaways
- The patent primarily covers specific chemical compositions and their associated therapeutic uses.
- Claims range from narrow (specific compounds) to broad (generic formulas or uses).
- The patent's protection end date is estimated between 2032-2034.
- Similar patents in other jurisdictions may limit market entry without licensing negotiations.
- The landscape suggests a strategic focus on key territories, with potential for expanding protection through international filings.
FAQs
1. Can the claims of UA99833 be challenged?
Yes. Challenges can be based on lack of novelty or inventive step if prior art shows similar compounds or methods.
2. What possible legal strategies exist around UA99833?
Opposition, invalidation proceedings, or licensing negotiations. Monitoring claim scope and competing patents guides these actions.
3. How does international patent protection influence UA99833’s value?
Filing in major markets (US, EU, WO) extends patent coverage and market exclusivity, affecting valuation and licensing prospects.
4. What is the likelihood of patent expiry leading to generics in Ukraine?
If no extension is applied, expiry is expected around 2032-2034, opening generic competition.
5. Which factors determine the enforceability of UA99833?
Claim clarity, prior art, and whether the patent is properly maintained and litigated influence enforceability.
References
[1] Ukrainian Patent Office. (2022). Patent documentation.
[2] WIPO. (2022). Patent landscape reports.
[3] European Patent Office. (2022). Patent analysis tools.
[4] US Patent and Trademark Office. (2022). Patent search database.
[5] World Intellectual Property Organization. (2022). Patent information services.
